BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsBlinatumomab Injection for Pediatric ALL Treatment
    Closed contract

    Blinatumomab Injection for Pediatric ALL Treatment

    Contract value
    €165.6k
    Closed 23 Jul 2025

    This contract is for the procurement of a medication containing the active ingredient blinatumomab, specifically a powder for infusion concentrate. Each vial contains 38.5 micrograms of blinatumomab, which, when reconstituted with sterile water, results in a final concentration of 12.5 micrograms/ml

    🇸🇰SlovakiaPublished 5 Jun 2025· 1 years agoviaTED
    Contract value
    €165.6k
    Closed 23 Jul 2025
    Tender deadline passed on 23 Jul 2025.

    Decision brief

    4 fields
    • Contract value
      est.€165,611
      Euros
    • Tender closed
      23 Jul 2025
      1 years ago
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇸🇰Slovakia

    Lifecycle

    Closed

    Tender closed on 23 Jul 2025. Awaiting award.

    5 Jun 2025Today23 Jul 2025

    Brief

    This contract is for the procurement of a medication containing the active ingredient blinatumomab, specifically a powder for infusion concentrate. Each vial contains 38.5 micrograms of blinatumomab, which, when reconstituted with sterile water, results in a final concentration of 12.5 micrograms/ml. The medication is indicated for use as a monotherapy in pediatric patients aged 1 month or older for the treatment of acute lymphoblastic leukemia (ALL) originating from precursor B-cells that are Philadelphia chromosome-negative and CD19-positive. It is intended for patients who are refractory or have relapsed after at least two prior treatments or have relapsed following a previous allogeneic stem cell transplant. Additionally, it is indicated for high-risk patients in their first relapse as part of consolidation therapy. The total contract value is €165,611.20, and the deadline for submissions is July 23, 2025. For more details, please visit the contract platform at TED.

    Track record

    2 awards · 2 winners
    Thin record

    Only 2 prior awards here — too little to read.

    In healthcare medical, CHILDRENS FACULTY HOSPITAL WITH POLYCLINIC BANSK BYSTRICA has awarded 2 contracts to 2 suppliers.

    Who wins here
    1. MED - ART, spol. s r.o.1× · 50%
    2. MED ART SPOL S RO1× · 50%

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from CHILDRENS FACULTY HOSPITAL WITH POLYCLINIC BANSK BYSTRICA

    1 listingView all →
    AwardedHealthcare & Medical🇸🇰Slovakia

    Velmanase Alpha 10 mg Powder for Infusion Solution

    This contract involves the procurement of a medication containing the active ingredient Velmanase alpha, in a dosage of 10 mg as a powder for infusion solution. The product is intended for intravenous use and is presented as a white to almost white powder. It is indicated for enzyme replacement ther

    €604,260CHILDRENS FACULTY HOSPITAL WITH POLYCLINIC BANSK BYSTRICA
    Published 6 Oct 2025

    Open in Healthcare & Medical

    4 open listingsView all →
    OpenHealthcare & Medical🇬🇧United Kingdom

    Global TB Screening Service Procurement

    UK Home Office seeks a global tuberculosis screening service provider to manage visa applicant testing across international locations through various delivery models.

    HOME OFFICE
    Published 14 Aug 2026
    Healthcare & Medical🇬🇧United Kingdom

    Technology Enabled Care Services Contract

    Norfolk County Council is seeking a contractor to provide technology-enabled and virtual care services that help residents maintain independence and improve outcomes while remaining in their own homes.

    est.£12,700,000NORFOLK COUNTY COUNCIL
    Published 14 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Liaison and Diversion, Reconnect and Mental Health Treatment Services for Lancashire and Cumbria

    Market engagement RFI for integrated criminal justice liaison, prison reentry and mental health treatment services across Lancashire and Cumbria, closing 4 September 2026.

    NHS England - North West
    Published 14 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Pralidoxime Chloride Supply 2026 - Market Engagement

    UKHSA is seeking supplier participation in a market engagement exercise for Pralidoxime Chloride supply in 2026 through a formal Request for Information process.

    £1nominalSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
    Published 14 Aug 2026
    Take action
    View on sourceTED

    Original closed notice on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    366899-2025
    CF
    Buyer
    CHILDRENS FACULTY HOSPITAL WITH POLYCLINIC BANSK BYSTRICA
    Sector
    Healthcare & Medical